• Global, South Africa
• Aspen, Bolt-on acquisition, Pharmaceutical, Transformative acquisition
• September 10, 2020

Aspen Pharmacare is a R60bn pharmaceuticals giant that used to be a lot bigger. The share price is down over 57% in 5 years, reflecting an unsuccessful strategy to push into developed as well as emerging markets, all while steadily building up a debt pile. It’s a story that seems to play out over and over again: South African corporates …